Surgery Partners (NASDAQ:SGRY) Price Target Cut to $24.00 by Analysts at Barclays
Surgery Partners (NASDAQ:SGRY – Get Free Report) had its target price cut by equities researchers at Barclays from $25.00 to $24.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Barclays‘s price target would suggest a potential upside of 4.85% from the stock’s previous close. […]
Surgery Partners (NASDAQ:SGRY – Get Free Report) had its target price cut by equities researchers at Barclays from $25.00 to $24.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Barclays‘s price target would suggest a potential upside of 4.85% from the stock’s previous close. […]
